Compare MEDP & VMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | VMI |
|---|---|---|
| Founded | 1992 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 9.8B |
| IPO Year | 2016 | 1994 |
| Metric | MEDP | VMI |
|---|---|---|
| Price | $449.54 | $521.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $473.17 | ★ $500.33 |
| AVG Volume (30 Days) | ★ 309.6K | 178.8K |
| Earning Date | 04-22-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 0.63% |
| EPS Growth | ★ 20.98 | N/A |
| EPS | 4.28 | ★ 5.51 |
| Revenue | N/A | ★ $3,169,556,000.00 |
| Revenue This Year | $13.19 | $5.53 |
| Revenue Next Year | $7.75 | $5.59 |
| P/E Ratio | $104.64 | ★ $95.51 |
| Revenue Growth | N/A | ★ 14.52 |
| 52 Week Low | $291.28 | $310.00 |
| 52 Week High | $628.92 | $535.32 |
| Indicator | MEDP | VMI |
|---|---|---|
| Relative Strength Index (RSI) | 56.69 | 62.45 |
| Support Level | $447.80 | $391.12 |
| Resistance Level | $477.04 | $528.49 |
| Average True Range (ATR) | 14.05 | 14.76 |
| MACD | 5.18 | -1.32 |
| Stochastic Oscillator | 90.75 | 73.24 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting, transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.